C1GALT1C1L: A Potential Drug Target and Biomarker (G728819)

Target Name: C1GALT1C1L

NCBI ID: G728819

C1GALT1C1L

Other Name(s): C1GALT1-specific chaperone 1-like protein | C1GALT1 specific chaperone 1 like | C1GALT1-specific chaperone 1-like | hCG1645220 | C1C1L_HUMAN

C1GALT1C1L: A Potential Drug Target and Biomarker

Chaperones are proteins that play a crucial role in the proper functioning of various cellular processes. These proteins help to transport and facilitate the movement of molecules within the cell, ensuring that essential components reach their intended destination and that waste products are removed. C1GALT1C1L, also known as C1GALT1-specific chaperone 1-like protein, is a chaperone that has been identified as a potential drug target and biomarker.

C1GALT1C1L is a protein that is expressed in various tissues and cells throughout the body, including the brain, heart, liver, and muscle. It is characterized by its unique structure, which consists of a long amino acid sequence that is specific to this protein. The sequence consists of a catalytic center, a hydrophobic region, and a hydrophilic region. The catalytic center is the site where C1GALT1C1L carries out its chaperone functions, such as interacting with other proteins and molecules to transport them to their intended destinations.

One of the unique features of C1GALT1C1L is its specificity for the protein known as C1GALT1. C1GALT1 is a protein that is expressed in various tissues and cells throughout the body, including the brain, and plays a crucial role in the development and maintenance of neural circuits. It is known for its ability to interact with other proteins and molecules, including C1GALT1C1L, which allows it to transport these proteins to their intended destinations.

The chaperone function of C1GALT1C1L is crucial for the proper functioning of various cellular processes. It helps to transport essential nutrients and waste products to their intended destinations, ensuring that the cell remains functioning optimally. C1GALT1C1L is also involved in the regulation of various cellular processes, including cell signaling, DNA replication, and metabolism.

As a potential drug target, C1GALT1C1L has been identified as a target for various therapeutic strategies. For example, researchers have used small molecules and antibodies to interact with C1GALT1C1L and modulate its chaperone function. These strategies have the potential to treat various diseases, including neurodegenerative disorders, cancer, and cardiovascular disease.

In addition to its potential as a drug target, C1GALT1C1L has also been identified as a potential biomarker. Its unique chaperone function makes it an attractive candidate for use as a diagnostic marker or therapeutic target. Researchers have used various techniques, such as mass spectrometry and affinity purification, to identify and quantify C1GALT1C1L in various tissues and cells. These studies have the potential to provide valuable information about the biology of C1GALT1C1L and its potential as a drug target or biomarker.

In conclusion, C1GALT1C1L is a protein that has been identified as a potential drug target and biomarker. Its unique chaperone function and its specificity for the protein C1GALT1 make it an attractive candidate for use in various therapeutic strategies. Further research is needed to fully understand the biology of C1GALT1C1L and its potential as a drug target and biomarker.

Protein Name: C1GALT1 Specific Chaperone 1 Like

The "C1GALT1C1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1GALT1C1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets